GoHealth, Inc. GOCOQ
0.34
0.00
0.00%
as of 28 Jul
- Market cap
- $8.5M
- P/E
- 0.0×
Follow GOCOQ
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,946.00 | 1,946.00 | — |
P/S ratio |
0.08 | 0.17 | 0.17 | 0.14 | 0.38 | 1.31 | 0.00 | 0.00 | — |
P/FCF ratio |
0.00 | 0.00 | 1.27 | 1.81 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(0.71) | 9.15 | 1.71 | (2.09) | (1.77) | (8.04) | (68.29) | (68.29) | — |
P/B ratio |
0.00 | 0.33 | 0.30 | 0.16 | 0.45 | 0.82 | 4.59 | 4.59 | — |
Price to Tangible BV |
0.00 | 1.30 | 13.37 | 2.05 | 1.35 | 3.55 | 4.59 | 4.59 | — |
EV/Sales |
2.29 | 0.95 | 1.00 | 1.32 | 1.19 | 1.81 | 0.00 | 0.00 | — |
EV/EBITDA |
0.00 | 7.03 | 26.84 | 0.00 | 184.66 | 43.63 | 0.00 | 0.00 | — |
EV/Operating CF |
(6.79) | (35.07) | 6.70 | 13.67 | (4.22) | (13.92) | (738.43) | (738.43) | — |
EV/FCF |
(6.36) | (21.44) | 7.67 | 17.56 | (3.96) | (12.35) | (87.48) | (87.48) | — |
Quick Ratio |
1.93 | 1.08 | 1.15 | 1.34 | 1.71 | 2.75 | 1.22 | 0.00 | — |
Current Ratio |
2.02 | 1.18 | 1.29 | 1.56 | 1.98 | 3.08 | 1.27 | — | — |
Net Debt/EBITDA |
(2.34) | 5.79 | 22.38 | (3.58) | 125.89 | 12.05 | 553.60 | 0.11 | — |
Debt/Assets |
80.34% | 44.68% | 46.74% | 46.00% | 45.67% | 27.65% | 24.26% | 0.00% | 0.00% |
Debt/Equity |
(12.75) | 1.64 | 1.73 | 1.41 | 1.06 | 0.42 | 0.45 | 0.00 | — |
Asset Turnover |
0.29 | 0.53 | 0.47 | 0.34 | 0.51 | 0.47 | 0.67 | 0.00 | — |
Operating CF/Net income |
0.47 | 3.28 | (1.63) | (0.41) | 1.58 | 6.07 | 0.00 | 0.19 | — |
Capex/Depreciation |
(0.09) | (0.12) | (0.13) | (0.12) | (0.04) | (0.14) | (0.24) | (1.00) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (152.11%) | (1.62%) | (14.10%) | (20.86%) | (16.53%) | (1.66%) | (12.20%) | 44.63% | — | |
| (21.09%) | (0.44%) | (4.23%) | (8.03%) | (9.07%) | (1.01%) | (5.13%) | 0.00% | — | |
ROIC |
(36.96%) | (0.43%) | (5.03%) | (15.45%) | (17.45%) | (2.19%) | (1.66%) | 449.42% | — |
Return on Tangible Assets |
(174.69%) | (7.19%) | (50.14%) | (85.82%) | (80.17%) | (6.67%) | (110.87%) | 234.31% | — |
Average Days of Receivables |
241.81 | 148.42 | 167.16 | 196.75 | 98.24 | 85.59 | 84.93 | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
86.56% | 67.62% | 69.06% | 92.61% | 73.65% | 64.92% | 46.15% | 44.94% | — |
Intangible Assets out of Total Assets |
0.00 | 0.20 | 0.26 | 0.30 | 0.29 | 0.51 | 0.73 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
2.53% | 1.41% | 2.66% | 4.30% | 2.57% | 24.65% | 16.22% | 0.00% | — |
Graham Net Nets |
(27.45) | (5.11) | (5.08) | (8.21) | (1.86) | (0.28) | 0.08 | 0.08 | — |
Graham Number |
44.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(858.14%) | (5.53%) | (55.16%) | (172.70%) | (44.04%) | (3.33%) | 0.05% | 0.05% | — |
Free Cash Flow Yield |
(467.97%) | (26.44%) | 78.44% | 55.40% | (79.36%) | (11.19%) | (1.31%) | (1.31%) | — |
Revenue per Share |
27.96 | 80.05 | 79.06 | 74.80 | 150.36 | 156.33 | 0.00 | 37.70 | — |
Operating CF per Share |
(9.42) | (2.16) | 11.75 | 7.21 | (42.32) | (20.35) | 0.00 | 0.91 | — |
Capex per Share |
(0.64) | (1.38) | (1.48) | (1.60) | (2.80) | (2.59) | 0.00 | (1.03) | — |
Free Cash Flow per Share |
(10.06) | (3.54) | 10.27 | 5.61 | (45.12) | (22.94) | 0.00 | (0.12) | — |
Cash per Share |
2.54 | 4.10 | 9.77 | 1.95 | 11.94 | 25.70 | 0.00 | 0.17 | — |
Shareholders Equity per Share |
(4.81) | 40.63 | 43.66 | 64.23 | 126.31 | 249.31 | 0.00 | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(4.81) | 40.63 | 43.66 | 64.23 | 126.31 | 249.31 | 0.00 | 0.00 | — |
Free Cash Flow |
(130.19) | (35.34) | 95.41 | 47.39 | (318.81) | (128.74) | (8.02) | (0.73) | — |
Working Capital |
144.29 | 62.36 | 106.43 | 149.10 | 211.93 | 264.45 | 30.70 | — | — |
Capital Expenditures |
(8.25) | (13.73) | (13.73) | (13.51) | (19.80) | (14.52) | (8.02) | (6.17) | — |
Net Current Asset Value |
(763.80) | (682.57) | (617.48) | (702.33) | (747.37) | (317.82) | (598.38) | 0.00 | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 | — |
Net Profit Margin |
(72.14%) | (0.82%) | (9.10%) | (23.69%) | (17.82%) | (2.14%) | (7.61%) | 12.43% | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
17.04 | 3.92 | 4.06 | 4.35 | 20.45 | 5.82 | 5.28 | 0.51 | — |
Cash ROIC |
(16.64%) | (4.58%) | 6.87% | 2.69% | (16.82%) | (6.19%) | (0.50%) | (109.28%) | — |
Accounts Receivable Turnover |
1.28 | 2.42 | 2.17 | 2.02 | 4.32 | 5.30 | 3.26 | 0.00 | — |
Accounts Payable Turnover |
8.94 | 8.09 | 9.68 | 6.83 | 9.85 | 17.85 | 7.13 | 3.34 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
26.29 | 40.78 | 40.65 | 29.46 | 60.76 | 16.00 | 29.24 | 155.96 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
282.28 | 330.66 | 338.48 | 313.22 | 245.84 | 165.64 | 165.64 | — | — |
Average Payables |
10.76 | 16.15 | 16.43 | 27.50 | 24.29 | 11.16 | 23.79 | 23.79 | — |
Average Assets |
1,237.90 | 1,494.00 | 1,579.43 | 1,864.07 | 2,088.82 | 1,855.55 | 801.15 | 0.00 | — |
Average Common Equity |
171.62 | 405.55 | 474.03 | 717.44 | 1,145.82 | 1,129.65 | 336.57 | 63.00 | — |
Columns are period end dates